2020
DOI: 10.1016/j.clinph.2019.10.020
|View full text |Cite
|
Sign up to set email alerts
|

Neurophysiological markers of cue reactivity and inhibition subtend a three-month period of complete alcohol abstinence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 67 publications
0
22
0
Order By: Relevance
“…A minimum of 20 accepted trials for both the Go and the No-go trials was required (by session) to average and compute the related “Go” and “No-go” ERP components. Specific “inhibitory No-go effects” tagging IC skills were obtained by computing the difference “No-go minus Go” waveform, 20,33-36 giving rise to the No-go N2d and P3d (d for difference) waves (Figure 2). As ERP latencies provide information regarding the processing speed, the individual latency has been quantified, according to the peak latency method.…”
Section: Methodsmentioning
confidence: 99%
“…A minimum of 20 accepted trials for both the Go and the No-go trials was required (by session) to average and compute the related “Go” and “No-go” ERP components. Specific “inhibitory No-go effects” tagging IC skills were obtained by computing the difference “No-go minus Go” waveform, 20,33-36 giving rise to the No-go N2d and P3d (d for difference) waves (Figure 2). As ERP latencies provide information regarding the processing speed, the individual latency has been quantified, according to the peak latency method.…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, there could be evidence of greater homogeneity when used to assess the clinical course of patients. Since they show a great sensitivity to change along the treatment process ( 155 , 156 ). Possibly because they reflect the integrity of some cognitive components that we could consider as intermediate endophenotypes, or as “stepping stones” to the disorder, but also toward the clinical recovery ( 8 ).…”
Section: Discussionmentioning
confidence: 99%
“…By fostering a longitudinal follow-up and intra-individual ERP approach, recent works have tried to verify the clinical utility of such designs, in which ERP measurements are included just as one would include measurements of symptoms. In a study by our laboratory of alcohol-dependent patients undergoing a four-week detoxification program[ 109 ], we showed that monitoring the changes in dual-processes that are well-known to trigger addictions (No-go P3 for inhibition[ 110 ] and P3 for cue reactivity[ 111 ]), at the start and at the end of the program, can provide clues about the mechanisms involved in abstinence or relapse. Indeed, specific changes in cognitive ERP markers during detoxification (a preserved oddball P3 and an enhanced No-go P3) indexed complete abstinence (over a 3-mo period) in alcoholic patients.…”
Section: Using Erps In Psychiatry: What Perspectives?mentioning
confidence: 99%
“…Therefore, merging test-retest ERP data with behavioral performances would allow identification of patients who need to recover more neural resources to achieve better performance ( e.g. , an increase of inhibitory No-go P3 resources to maintain abstinence in alcoholic patients[ 109 ]), while patients exhibiting compensatory or exacerbated mechanisms may need to reduce the activity allocated to the task ( e.g. , decreased ERN in anxiety disorders to assess better emotional regulation[ 56 ]).…”
Section: Using Erps In Psychiatry: What Perspectives?mentioning
confidence: 99%
See 1 more Smart Citation